The expression of CD25 by flow cytometry (FC) has been described as a poor prognostic factor in ALL, and it was suggested to be a valuable biomarker to identify a subset of patients with Ph+ who would benefit from a TKI-based chemotherapy [6, 10]. Here, IL2RA is linked to acute lymphoblastic leukemia.